VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
MNPRMonopar Therapeutics Inc.
$81.77$548M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMNPRDividend History

MNPR logoMonopar Therapeutics Inc. (MNPR) Dividend History

Income profile from 2015 to 2025 with payout safety and yield-on-cost trend

Trailing Dividend / Share
$0.00
0 payments in last 12 months
Dividend Yield
N/A
Current annualized yield
Payout Ratio
N/A
Unknown
Dividend Streak
0 years
Consecutive annual increases
5Y Dividend CAGRN/A
Current Yield on CostN/A
Yield on Cost Trendunknown

MNPR Dividend Income Check

Safety

Payout ratio data not available yet.

Consistency

0 straight years of dividend increases.

Income Trend

Yield on cost trend needs more history.

MNPR Dividend Scorecard

Yield & Income

Dividend YieldN/A
Trailing DPS$0.00
FrequencyN/A
Payments / 12M0

Payout Safety

Earnings PayoutN/A
Earnings SafetyUnknown
FCF PayoutN/A
FCF SafetyUnknown
Piotroski F-Score5/9

Growth

Growth Streak0 years
3Y CAGRN/A
5Y CAGRN/A
Yield on Cost (5Y)N/A
YOC Trendunknown

Total Returns

Buyback Yield6.4%
Total Shareholder Yield6.4%
1Y Total Return156.9%
5Y Total Return172.1%
Estimated $10K growth (return + dividends):
5Y ago$27,21110Y ago$6,17120Y ago$6,171

Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). MNPR's recent 5Y regime has been stronger than its full 10Y period, so 5Y can appear higher than 10Y.

MNPR Dividend History

No dividend payment history available

This company has not paid dividends during the available data period.

Get MNPR's next ex-dividend date and payout in your inbox

Monthly dividend calendar — upcoming ex-dates for stocks you follow.

Free. Unsubscribe any time.

Dividend Analysis

Payout Safety

Monopar Therapeutics Inc. has limited earnings payout data (Unknown).

Piotroski F-Score: 5/9 — moderate financial health.

Growth Track Record

MNPR does not have a current streak of consecutive dividend increases.

Total Shareholder Returns

Beyond cash dividends, MNPR returns capital through share repurchases. The combined picture: 6.4% buyback yield, 6.4% total shareholder yield.

Income Trend & Total Return

The 5-year total return is 172.1%.

DRIP Growth

A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $6,171 today.

MNPR Dividend vs Peers

Comparable companies in the same industry

Div Yield
—
—
Safety
Unknown
— payout
Streak
0Y
— 5Y CAGR
Total Shareholder
6.4%
#3 of 3
CompanyMkt CapYieldPayoutFCF PayoutStreak5Y GrowthBuybackTSY1Y ReturnSafety
MNPR logoMNPRMonopar Therapeutics…
$548M———0—6.4%6.4%156.9%Unknown
2nd
TPVG logoTPVGTriplePoint Venture …
$192M21.7%83.9%—0-8.6%0.0%21.7%-15.4%Watch
1st
CASI logoCASICASI Pharmaceuticals…
$2M31.1%——0—0.0%31.1%-87.8%Unknown

MNPR Annual Dividend History (2015–2025)

11 years of dividend data

GrowthDecline
YearDPSYoYPmtsEPSPayoutCoverageFCF/ShareFCF PayoutBuyback YldTotal Shld YldYOC
2025$0.00—0$-1.85——$-1.65—7.2%7.2%—
2024$0.00—0$-1.36——$-0.56—0.0%0.0%—
2023$0.00—0$-0.58——$-0.54—0.0%0.0%—
2022$0.00—0$-0.83——$-0.57—0.0%0.0%—
2021$0.00—0$-0.73——$-0.59—0.0%0.0%—
2020$0.00—0$-0.58——$-0.43—0.0%0.0%—
2019$0.00—0$-0.40——$-0.29—0.0%0.0%—
2018$0.00—0$-0.31——$-0.28————
2017$0.00—0$-1.59——$-0.25————
2016$0.00—0$-0.12——$-0.12————
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

11+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

MNPR — Frequently Asked Questions

Quick answers to the most common questions about buying MNPR stock.

How much dividend does MNPR pay per share?

Monopar Therapeutics Inc. (MNPR) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.

When is MNPR's next ex-dividend date?

MNPR's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. MNPR typically pays dividends quarterly.

Is MNPR's dividend safe?

MNPR's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.

How many years has MNPR increased its dividend?

MNPR has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.

How often does MNPR pay dividends?

Monopar Therapeutics Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 10+ years from 2015 to 2025.

How much would $10,000 invested in MNPR grow with dividend reinvestment?

With dividends reinvested (DRIP), $10,000 invested in MNPR five years ago would be worth approximately $27,211 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.

What is MNPR's yield on cost for long-term holders?

MNPR's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.